Analysis of 17-Hydroxyprogesterone in Serum for Clinical Research

Importance of the Topic

The quantification of 17-hydroxyprogesterone (17-OHP) in serum is critical for clinical research into adrenal and steroid biosynthesis disorders. Accurate measurement at low physiological concentrations supports diagnostic studies, pharmacokinetic evaluations, and quality assessment of laboratory methods.

Objectives and Overview of the Study

This application note describes the development and validation of an automated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for serum 17-OHP analysis. The primary goals were to achieve high sensitivity and selectivity, evaluate method precision and linearity, and assess agreement with external quality assessment (EQA) samples.

Methodology and Instrumentation

The workflow combines Oasis PRiME HLB µElution plate solid-phase extraction (SPE) with multi-well automation on a Tecan Freedom EVO® 100/4 liquid handler. Chromatographic separation was performed on a Waters ACQUITY UPLC I-Class system using HSS T3 columns and a VanGuard pre-column with a water/methanol gradient containing ammonium acetate and formic acid. Detection employed a Xevo TQD mass spectrometer in positive electrospray mode with multiple reaction monitoring (MRM). Stable isotope-labeled internal standard 17-OHP-13C3 was used for quantification.

Main Results and Discussion

• No interferences were observed from eleven structurally related steroids, demonstrating excellent chromatographic selectivity and baseline resolution of 17-OHP from its isobaric contaminant.
• The method achieved a lower limit of quantification of 0.76 nmol/L with precision under 20% RSD and signal-to-noise ratios above 10:1 across replicates.
• Total precision across low, mid, and high QC levels (1.5, 30, 227 nmol/L) ranged from 4.5% to 8.2% CV, with repeatability between 3.8% and 8.2% CV.
• Linearity was confirmed over 0.68–333 nmol/L (r2>0.994) in spiked serum.
• Matrix effect evaluations in six individual donor sera showed minimal ion suppression (mean matrix factor 0.92–0.96; RSD ≤5.5%).
• EQA sample comparison (n=50) via Deming regression yielded y=0.93x+0.14 (r=0.998) and a mean bias of –5.0% by Bland-Altman analysis, confirming method accuracy against external benchmarks.

Benefits and Practical Application

The protocol requires only 100 µL of serum, reduces manual handling through automation, and delivers high throughput with reliable assay performance. Its robust sensitivity and selectivity make it well suited for clinical research settings and large-scale studies of steroid metabolism.

Future Trends and Potential Uses

Ongoing advancements may include integration of higher-capacity SPE formats, further miniaturization of sample volumes, and expansion to multiplexed steroid panels. Emerging data analysis tools and machine learning approaches could enhance quality control and biomarker discovery in endocrinology research.

Conclusion

An automated LC-MS/MS method for serum 17-OHP using Oasis PRiME HLB µElution plates and ACQUITY UPLC-Xevo TQD instrumentation offers sensitive, selective, and reproducible quantification. Validation data demonstrate excellent precision, linearity, and agreement with EQA samples, establishing the method as a reliable platform for clinical research.

Reference

• Foley D, Wills M, Calton L. Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate for Clinical Research. Waters Application Note. 2016;720005554EN.